Lunai Bioworks Inc.
RENB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $28,601 | $477,029 | $88,148 | $135,286 |
| - Cash | $625 | $93 | $923 | $312 |
| + Debt | $2,707 | $10,173 | $7,579 | $6,366 |
| Enterprise Value | $30,683 | $487,110 | $94,804 | $141,341 |
| Revenue | $0 | $193 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | $0 | $96 | -$32 | -$32 |
| % Margin | – | 50% | – | – |
| EBITDA | -$3,267 | -$126,512 | $410 | -$7,121 |
| % Margin | – | -65,571.8% | – | – |
| Net Income | $2,819 | -$126,732 | $189 | -$7,252 |
| % Margin | – | -65,686.2% | – | – |
| EPS Diluted | 0.13 | 2.16 | 0.012 | -0.448 |
| % Growth | -94% | 17,900% | 102.7% | – |
| Operating Cash Flow | -$1,349 | -$1,811 | $11,774,533,424 | -$2,560 |
| Capital Expenditures | $0 | $0 | $29,773,976 | $0 |
| Free Cash Flow | -$1,349 | -$1,811 | $11,804,307,400 | -$2,560 |